Reference
FDA. FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone Internet Document : 6 Aug 2020. Available from: URL: https://www.fda.gov/news-events/press-announcements/fda-requiring-labeling-changes-opioid-pain-medicines-opioid-use-disorder-medicines-regarding
Rights and permissions
About this article
Cite this article
FDA requires labelling changes for drugs treating opioid overdose. Reactions Weekly 1817, 2 (2020). https://doi.org/10.1007/s40278-020-81961-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-81961-7